18 May 2019 - Actually cutting health care costs will require overcoming opposition instead of ducking it, as his administration did this week.
The Trump administration makes a lot of noise about drug pricing. Its actions so far aren’t as resounding.
This dynamic was on display Thursday, when the administration moved forward with a regulation that will help privately run Medicare Advantage plans that cover about 20 million seniors negotiate prices on some medicines. But at the same time, it decided not to go ahead with a planned change that could have cut costs in a larger program. The net result is that the overall impact is dulled.